All Stories

  1. Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
  2. Personalizing the approach to asthma treatment
  3. Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps
  4. Asthma
  5. Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
  6. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
  7. Umeclidinium for the treatment of uncontrolled asthma
  8. Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations
  9. Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
  10. Personalized Medicine in Allergy
  11. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
  12. Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases
  13. The path to personalized medicine in asthma
  14. Biosimilars in allergic diseases
  15. Update on immunotherapy for the treatment of asthma
  16. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma
  17. New Therapies for Allergic Rhinitis